Ahmed Syed E, Khan Afaque H
Heartland Behavioral Healthcare, Department of Mental Health and Addiction, State of Ohio, Northeast Ohio Medical University.
Psychiatry, Heartland Behavioral Healthcare, Department of Mental Health and Addiction, State of Ohio, Northeast Ohio Medical University.
Cureus. 2017 Aug 9;9(8):e1553. doi: 10.7759/cureus.1553.
We are reporting a case of psychogenic polydipsia from a State of Ohio psychiatric hospital. The patient has a known five-year history of psychogenic polydipsia with recurrent hyponatremia and has been diagnosed with schizoaffective disorder bipolar type 1, according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria, for the past two decades. There was a marked improvement with the use of acetazolamide, resulting in a decreased compulsion to drink fluid and improvement of his hyponatremia. The patient was observed for six months. We evaluated the water balance of the patient with diurnal weight measurements (DWG) and a weekly comprehensive metabolic panel (CMP) to monitor Na⁺ levels. His symptoms and hyponatremia were improved with acetazolamide. The treatment was well tolerated without any adverse effects and improved his quality of life.
我们报告了一例来自俄亥俄州一家精神病医院的精神性烦渴病例。该患者有已知的五年精神性烦渴病史，伴有反复低钠血症，根据《精神疾病诊断与统计手册》第五版（DSM - 5）标准，在过去二十年中被诊断为双相1型精神分裂症。使用乙酰唑胺后有显著改善，导致饮水冲动减少，低钠血症得到改善。对该患者进行了六个月的观察。我们通过每日体重测量（DWG）和每周一次的综合代谢指标检测（CMP）来评估患者的水平衡，以监测钠离子水平。乙酰唑胺改善了他的症状和低钠血症。该治疗耐受性良好，无任何不良反应，并改善了他的生活质量。
